SCHEMBL3787417

SCHEMBL3787417

Nc1cccc(C2=CC=CCC2(N)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MCL1 Q07820 1/20 0.36
MAP4K4 O95819 4/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
PSIP1 O75475 1/20 0.33
AXL P30530 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
RECQL P46063 1/20 0.33
NPY5R Q15761 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
CA7 P43166 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29011263 0.83 ALDH1A1 (0.33) MAOAALDH1A1MAPTMEN1NPY5R
SCHEMBL3781938 0.82 MAOA (0.37) MAOAMCL1MAP4K4KDM4EMAPT
SCHEMBL3789287 0.81 MAOA (0.39) MAOAMCL1MAP4K4ALDH1A1KDM4E
SCHEMBL3790447 0.81 MAOA (0.39) MAOAMCL1MAP4K4ALDH1A1KDM4E
SCHEMBL3786705 0.81 ALDH1A1 (0.37) MAOAMCL1MAP4K4ALDH1A1KDM4E
SCHEMBL3788292 0.79 MAOA (0.37) MAOAMCL1MAP4K4KDM4EMEN1
SCHEMBL3808739 0.79 MAOA (0.37) MAOAMCL1MAP4K4ALDH1A1KDM4E
SCHEMBL3787570 0.79 MAOA (0.41) MAOAMCL1MAP4K4ALDH1A1KDM4E
SCHEMBL3787247 0.78 MAOA (0.36) MAOAMCL1MAP4K4KDM4EMEN1
SCHEMBL3784580 0.78 MAOA (0.36) MAOAMCL1MAP4K4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAOA 348/4885MCL1 3100/4885MAP4K4 3704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.